This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 52 print issues and online access 185,98 per year only 3,58 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
By the end, youll understand how Semaglutide works, why it excels at reducing belly fat, and why your next step toward a healthier middle might be as precise as a weekly shot
Glucagon-like peptide-1 receptor agonists (GLP-1s), such as Ozempic and Mounjaro, have become popular medications for controlling diabetes and treating obesity but new Canadian research suggests they can also lead to a paradoxical side effect in the form of eye problems
pregnant or breastfeeding individuals (discontinue at least 2 months before planned pregnancy)